Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Corcept Therapeutics (CORT) Tax Rate (2017 - 2025)

Historic Tax Rate for Corcept Therapeutics (CORT) over the last 9 years, with Q3 2025 value amounting to 29.03%.

  • Corcept Therapeutics' Tax Rate fell 398500.0% to 29.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 19.96%, marking a year-over-year decrease of 346800.0%. This contributed to the annual value of 12.56% for FY2024, which is 22300.0% down from last year.
  • Per Corcept Therapeutics' latest filing, its Tax Rate stood at 29.03% for Q3 2025, which was down 398500.0% from 11.04% recorded in Q2 2025.
  • In the past 5 years, Corcept Therapeutics' Tax Rate registered a high of 31.61% during Q4 2022, and its lowest value of 113.63% during Q1 2025.
  • In the last 5 years, Corcept Therapeutics' Tax Rate had a median value of 14.1% in 2023 and averaged 2.1%.
  • Its Tax Rate has fluctuated over the past 5 years, first surged by 333500bps in 2022, then plummeted by -1342900bps in 2025.
  • Over the past 5 years, Corcept Therapeutics' Tax Rate (Quarter) stood at 12.75% in 2021, then soared by 148bps to 31.61% in 2022, then crashed by -53bps to 14.72% in 2023, then tumbled by -75bps to 3.7% in 2024, then crashed by -884bps to 29.03% in 2025.
  • Its Tax Rate stands at 29.03% for Q3 2025, versus 11.04% for Q2 2025 and 113.63% for Q1 2025.